Indevus Pharmaceuticals, Inc.

Indevus Pharmaceuticals is a publicly-traded biotechnology company who focuses on developing, and commercializing speciality pharmaceuticals and through internal R&D and strategic partnerships is advancing the state-of-art of drug delivery with its innovative Hydron Implant technology. Indevus was acquired by Endo Pharmaceuticals (NASDAQ: ENDP).